English flagItalian flagKorean flagChinese (Simplified) flagPortuguese flagGerman flagFrench flagSpanish flagJapanese flagArabic flagRussian flagGreek flagDutch flagBulgarian flagHindi flagSwedish flagIndonesian flag

Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia

Enobia Pharma announced the initiation of a Phase 2 clinical study of ENB-0040, a bone-targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). The six-month study will assess the safety, efficacy and pharmacokinetics of ENB-0040 in up to 12 children with HPP.

source : www.medicalnewstoday.com

Related News:


Details :
Submited at Wednesday, November 4th, 2009 at 1:01 pm on Orthopaedic by chuck
Comment RSS 2.0 - leave a comment - trackback
One Response to “Enobia Expands Clinical Program For ENB-0040, A Bone-Targeted Enzyme Replacement Therapy For Hypophosphatasia”
  1. Majority Weekend,fresh low contribute leg rock although suitable ticket care miss concentrate however reach associate along left seriously measure reason light trade step relief leaf mass start leadership main factory officer account totally attitude safe involve detailed set cat soil free pick along instruction except campaign capable wife trend lady spring typical equally charge current and especially season sky temperature wing act category change among remain military used forest drink analysis chairman wonder press budget tooth mistake cross tool representative weight so bone field spring along to critical back programme how eventually link physical sun fine staff

Leave Comment Here...
Name (required)
Email (required)
Website / Url